Richard A Creamer, in Lafayette, CO - General Practice

Richard A Creamer, is a General Practice physician based in Lafayette, Colorado. Richard A Creamer is licensed to practice in Colorado (license number 13483) and his current practice location is 280 Exempla Cir, Lafayette, Colorado. He can be reached at his office (for appointments etc.) via phone at (720) 536-7910.

NPI number for Richard A Creamer is 1295862209 and his current mailing address is 6088 Rogers Cir, Arvada, Colorado. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1295862209.

Contact Information

	Richard A Creamer,
	280 Exempla Cir, Lafayette, CO 80026-3370
	(720) 536-7910
	Not Available

Physician's Profile

Full Name	Richard A Creamer
Gender	Male
Speciality	General Practice
Location	280 Exempla Cir, Lafayette, Colorado
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1295862209
Provider Enumeration Date: 02/27/2007
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Richard A Creamer such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1295862209	NPI	-	NPPES
014788	Other		KAISER-COMMERCIAL NUMBER

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208D00000X	General Practice	13483 (Colorado)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Richard A Creamer is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Richard A Creamer, 6088 Rogers Cir, Arvada, CO 80403-2638 Ph: (303) 273-5435	Richard A Creamer, 280 Exempla Cir, Lafayette, CO 80026-3370 Ph: (720) 536-7910

News Archive

Alimera Sciences announces results from ongoing study on ILUVIEN

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, announced that Alimera Sciences Limited, its European subsidiary based in London, revealed interim six-month data on ILUVIEN (Fluocinolone Acetonide 190 micrograms intravitreal implant in applicator) from the ongoing study referred to as RESPOND, a non-Randomised, open-label, multicenter phase 4 pilot study on the Effect and Safety of ILUVIEN Fluocinolone Acetonide in chronic diabetic macular edema Patients cOnsidered iNsufficiently responsive to available therapies with or without intravitreal corticosteroiD therapy.

Internet-based educational program improves health-related quality of life for teens with JIA

An internet-based health education and self-management program that offers monthly calls with health coaches improved health-related quality of life for participating teens with juvenile idiopathic arthritis, according to new research findings presented this week at the 2017 ACR/ARHP Annual Meeting in San Diego.

Scientists at Seattle conference discuss progress, obstacles in fight against HIV/AIDS

"Scientists, stymied for decades by the complexity of the human immunodeficiency virus, are making progress on several fronts in the search for a cure for HIV infections," but "a major stumbling block is the fact that HIV lies low in pools or reservoirs of latent infection that even powerful drugs cannot reach, scientists told the Conference on Retroviruses and Opportunistic Infections, one of the world's largest scientific meetings on HIV/AIDS," in Seattle last week, Reuters reports.

Research findings may lead to new treatments, approaches for controlling multiple sclerosis

Scientists are gaining a new level of understanding of multiple sclerosis that may lead to new treatments and approaches to controlling the chronic disease, according to new research released today at Neuroscience 2013, the annual meeting of the Society for Neuroscience and the world's largest source of emerging news about brain science and health.

AVAC applauds CAPRISA 004 microbicide gel trial for preventing sexual transmission of HIV infection

"This is a historic day for HIV prevention research. The CAPRISA 004 results are the first clinical evidence that a microbicide gel can help to prevent sexual transmission of HIV infection," said AVAC Executive Director Mitchell Warren, reacting to the results of the landmark microbicide trial presented today at the International AIDS Conference in Vienna.

General Practice Doctors in Lafayette, CO

Brandi D Smalley, General Practice Medicare: Not Enrolled in Medicare Practice Location: 280 Exempla Cir, Lafayette, CO 80026 Phone: 303-743-5855
Viola Romero De Rio, General Practice Medicare: Not Enrolled in Medicare Practice Location: 280 Exempla Cir, Lafayette, CO 80026 Phone: 720-536-7578
Dennis W Thode, General Practice Medicare: Not Enrolled in Medicare Practice Location: 280 Exempla Cir, Lafayette, CO 80026 Phone: 720-536-7923
Barbara F Bowes, General Practice Medicare: Not Enrolled in Medicare Practice Location: 280 Exempla Cir, Lafayette, CO 80026 Phone: 720-536-6625
Alma S Navarro, General Practice Medicare: Not Enrolled in Medicare Practice Location: 280 Exempla Cir, Lafayette, CO 80026 Phone: 720-536-7919
Susan L Holsclaw, General Practice Medicare: Not Enrolled in Medicare Practice Location: 280 Exempla Cir, Lafayette, CO 80026 Phone: 720-536-7934
Anita T Nebel, PHARM.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 280 Exempla Cir, Lafayette, CO 80026 Phone: 720-536-7953

Richard A Creamer, - General Practice in Lafayette, CO